News | Image Guided Radiation Therapy (IGRT) | August 21, 2017

Summit Cancer Center-Boise Treats First Cancer Patients With Accuray Radixact System

Freestanding center is first in the western U.S. to treat patients with this "smart" radiation therapy delivery system with fully integrated treatment planning and data management systems

Summit Cancer Center-Boise Treats First Cancer Patients With Accuray Radixact System

August 21, 2017 — Accuray Inc. and the Summit Cancer Center-Boise announced that the center is now treating patients with the Radixact Treatment Delivery System, the next-generation TomoTherapy platform. The Radixact System replaced a competitive conventional linear accelerator in the single-vault freestanding facility.

The system provides precise and accurate treatments for more routine radiation therapy indications including skin, central nervous system, breast, head and neck, lung, prostate, gynecologic and gastrointestinal malignancies, in addition to more complex treatments such as craniospinal and total marrow irradiation. Additionally, Summit Cancer Center-Boise has the ability to perform stereotactic radiosurgery (SRS) and stereotactic body radiotherapy (SBRT).

"At Summit Cancer Center-Boise our goal is to use innovative technology to provide our patients with the treatment best suited to their needs. This system allows us to provide precise, individualized treatment while sparing normal tissues and maintaining optimal treatment efficacy," said John E. Gamboa, M.D., radiation oncologist, medical director of Summit Cancer Center-Boise.

The use of radiation as part of cancer treatment is increasing, both during initial treatment and increasingly for re-treatment, so the ability to deliver the correct dose precisely to the tumor is becoming even more important. The Radixact System was designed to deliver image-guided intensity-modulated radiation therapy, an extremely precise form of radiation therapy.

  • The system is built on a ring gantry platform with a computed tomography (CT) scanner. It provides continuous delivery of radiation from 360 degrees around the patient, or delivery from clinician-specified beam angles, ensuring the most precise treatment customized for each patient, minimizing exposure to healthy tissue and measurably mitigating side effects;
  • Treatment accuracy is achieved through daily 3-D image guidance, which ensures proper patient positioning and dose targeting even when anatomical changes occur. The system takes an image of the patient every day as part of the patient setup, enabling the clinical team to know exactly where the tumor is on that particular day;
  • The ultra-fast binary multileaf collimator (MLC) is a key component of the system, enabling it to deliver dose with extremely high precision and accuracy;
  • Continuous couch motion through the bore of the ring gantry facilitates seamless delivery to multiple targets or long volumes with no need for field matching, which would be required if using a conventional delivery device. This innovation in workflow also improves treatment quality by ensuring that highly-sculpted radiation doses can be delivered to tumors located anywhere in the body, regardless of the tumor size or the number of tumors receiving treatment;
  • A fully-integrated, simplified adaptive treatment planning solution, PreciseART Adaptive Radiation Therapy software, enables the clinical team to adjust therapy to changes in tumor size, shape and location — as well as subtle changes in the location of organs and other healthy tissue; and
  • The PreciseRTX Retreatment Option makes it easier for clinicians to deliver precise doses of radiation in those cases where, unfortunately, cancer has recurred and retreatment with radiation is necessary.

For more information: www.accuray.com

Related Content

Artificial intelligence (AI) will not force specialists in radiation oncology from their jobs but rather make them better at the jobs only they can do, said speakers at the annual meeting of the American Society of Radiation Oncology (ASTRO) in San Antonio, Texas.
Feature | Artificial Intelligence | October 22, 2018 | By Greg Freiherr
Artificial intelligence (AI) will not force specialists in radiation oncology from their jobs but rather make them be
News | Prostate Cancer | October 22, 2018
The first report of a large, international clinical trial shows that, for men who show signs of...

Image courtesy of Vital Images

News | ASTRO | October 22, 2018
Treatment of renal cell carcinoma with stereotactic radiation therapy is as safe and effective for patients with one
Fewer, larger individual doses of radiation lead to similar adverse effects to normal tissue after 10 years as with conventional radiation therapy for early breast cancer
News | ASTRO | October 22, 2018
In a 10-year study of women who received radiation therapy to treat early-stage breast cancer, those receiving fewer,
Patients whose cancer has not spread far past the lungs may benefit from targeting tumor sites with radiation or surgery after initial treatment, according to ASTRO study
News | ASTRO | October 21, 2018
Adding radiation therapy or surgery to systemic therapy for stage IV lung cancer patients whose cancer has spread to
DCIS, ductal carcinoma in situ, radiation therapy, survival benefit, Brigham and Women's Hospital study

Image courtesy of Barco

News | ASTRO | October 21, 2018
A subset of patients with low-risk breast cancer is highly unlikely to see cancer return following breast conservatio
The Elekta Unity with 1.5T MRI embedded as a targeting system appeared at the annual meeting of the American Society of Radiation Oncology (ASTRO) in San Antonio, Texas. The system is being sold in Europe and could soon enter the U.S. marketplace. (Photo courtesy of Elekta)

The Elekta Unity with 1.5T MRI embedded as a targeting system appeared at the annual meeting of the American Society of Radiation Oncology (ASTRO) in San Antonio, Texas. The system is being sold in Europe and could soon enter the U.S. marketplace. (Photo courtesy of Elekta)

Feature | ASTRO | October 20, 2018 | By Greg Freiherr
A linear accelerator combined with high-field MRI could soon be on the U.S. market. If U.S.
The Aquilion Precision CT system from Canon offers very high resolution imaging, which may aid in cancer detection and improved treatment planning in radiation oncology. #ASTRO2018 #ASTRO #ASTRO18

The Aquilion Precision CT system from Canon offers very high resolution imaging, which may aid in cancer detection and improved treatment planning in radiation oncology. 

News | Computed Tomography (CT) | October 19, 2018
October 19, 2018 – At the 2018 American Society of...
IBA's Proteus system and proton therapy solutions will be discussed at ASTRO 2018. #ASTRO18 #ASTRO #ASTRO2018
News | Proton Therapy | October 19, 2018
October 19, 2018 – IBA (Ion Beam Applications S.A.) is sharing how hospitals can secure performance, investment and t